Effect of synthetic thyrotrophin-releasing hormone and its analogues on growth hormone secretion in the domestic fowl (Gallus domesticus)

Sex- and Developmental Stage-Related Differences in the Hepatic Transcriptome of Japanese Quail (Coturnix japonica) Exposed to 17β-Trenbolone

Endocrine-disrupting chemicals can cause transcriptomic changes that may disrupt biological processes associated with reproductive function including metabolism, transport, and cell growth. We investigated effects from in ovo and dietary exposure to 17β-trenbolone (at 0, 1, and 10 ppm) on the Japanese quail (Coturnix japonica) hepatic transcriptome. Our objectives were to identify differentially expressed hepatic genes, assess perturbations of biological pathways, and examine sex- and developmental stage-related differences. The number of significantly differentially expressed genes was higher in embryos than in adults. Male embryos exhibited greater differential gene expression than female embryos, whereas in adults, males and females exhibited similar numbers of differentially expressed genes (>2-fold). Vitellogenin and apovitellenin-1 were up-regulated in male adults exposed to 10 ppm 17β-trenbolone, and these birds also exhibited indications of immunomodulation. Functional grouping of differentially expressed genes identified processes including metabolism and transport of biomolecules, enzyme activity, and extracellular matrix interactions. Pathway enrichment analyses identified as perturbed peroxisome proliferator-activated receptor pathway, cardiac muscle contraction, gluconeogenesis, growth factor signaling, focal adhesion, and bile acid biosynthesis. One of the primary uses of 17β-trenbolone is that of a growth promoter, and these results identify effects on mechanistic pathways related to steroidogenesis, cell proliferation, differentiation, growth, and metabolism of lipids and proteins. Environ Toxicol Chem 2021;40:2559-2570. © 2021 SETAC. This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Glucagon-like peptide (GCGL) is a novel potential TSH-releasing factor (TRF) in Chickens: I) Evidence for its potent and specific action on stimulating TSH mRNA expression and secretion in the pituitary

Our recent study proposed that the novel glucagon-like peptide (GCGL), encoded by a glucagon-like gene identified in chickens and other lower vertebrates, is likely a hypophysiotropic factor in nonmammalian vertebrates. To test this hypothesis, in this study, we investigated the GCGL action on chicken pituitaries. The results showed that: 1) GCGL, but not TRH, potently and specifically stimulates TSH secretion in intact pituitaries incubated in vitro or in cultured pituitary cells monitored by Western blotting or a cell-based luciferase reporter assay; 2) GCGL (0.1nM-10nM) dose dependently induces the mRNA expression of TSHβ but not 5 other hormone genes in cultured pituitary cells examined by quantitative real-time RT-PCR, an action likely mediated by intracellular adenylate cyclase/cAMP/protein kinase A and phospholipase C/inositol 1,4,5-trisphosphate/Ca(2+) signaling pathways coupled to GCGL receptor (GCGLR); 3) GCGLR mRNA is mainly localized in pituitary cephalic lobe demonstrated by in situ hybridization, where TSH-cells reside, further supporting a direct action of GCGL on thyrotrophs. The potent and specific action of GCGL on pituitary TSH expression and secretion, together with the partial accordance shown among the temporal expression profiles of GCGL in the hypothalamus and GCGLR and TSHβ in the pituitary, provides the first collective evidence that hypothalamic GCGL is most likely to be a novel TSH-releasing factor functioning in chickens. The discovery of this novel potential TSH-releasing factor (GCGL) in a nonmammalian vertebrate species, ie, chickens, would facilitate our comprehensive understanding of the hypothalamic control of pituitary-thyroid axis across vertebrates.

Expression and function of chicken bursal growth hormone (GH)

Growth hormone (GH) has several effects on the immune system. Our group has shown that GH is produced in the chicken bursa of Fabricius (BF) where it may act as an autocrine/paracrine modulator that participates in B-cell differentiation and maturation. The time course of GH mRNA and protein expression in the BF suggests that GH may be involved in development and involution of the BF, since GH is known to be present mainly in B lymphocytes and epithelial cells. In addition, as GH is anti-apoptotic in other tissues, we assessed the possibility that GH promotes cell survival in the BF. This work focused on determining the mechanism by which GH can inhibit apoptosis of B cells and if the PI3K/Akt pathway is activated. Bursal cell cultures were treated with a range of GH concentrations (0.1-100nM). The addition of 10nM GH significantly increased viability (16.7±0.6%) compared with the control and decreased caspase-3 activity to 40.6±6.5% of the control. Together, these data indicate that GH is produced locally in the BF and that the presence of exogenous GH in B cell cultures has antiapoptotic effects and increases B cell survival, probably through the PI3k/Akt pathway.

In vitro study of corticotropin-releasing hormone-induced thyrotropin release: ontogeny and inhibition by somatostatin

Recent research has shown that in the chicken important interactions take place between the adrenal and the thyroidal axis both at the central and the peripheral level. In vivo as well as in vitro experiments showed that ovine corticotropin-releasing hormone (oCRH) clearly increases thyrotropin (TSH) secretion in late embryonic and early posthatch chicks. In vivo experiments in older chickens, however, suggested that this response might disappear at a later stage. Therefore we started to study in detail the ontogeny of the TSH releasing activity of oCRH using the in vitro perifusion technique. Several embryonic stages (E14, E16, and E18) as well as posthatch stages (C1, C8, C22, and adult chickens) were included in the study. We also investigated the possible regulatory role of somatostatin (SRIH) in this specific endocrine function of CRH. The perifusion studies show that CRH stimulated the TSH release at all stages tested. The 10 and 100 nM oCRH doses were almost equally effective at the early embryonic stages while in most posthatch stages the higher oCRH dose was significantly more effective than the lower one. The stimulation factor, representative for the relative increase in TSH secretion following oCRH challenge, was high at early embryonic stages and clearly lower in adult animals. This seemed to be related to an age-dependent increase in basal TSH secretion levels. In both embryonic (E19) and posthatch (C8) chicks a pretreatment of the pituitaries with SRIH lowered the sensitivity of the thyrotropes to an oCRH challenge. This effect was more pronounced in the posthatch chicks compared to the embryos. The results show that CRH is capable of stimulating the TSH secretion during the entire life cycle of the chicken and that SRIH may play an important role in the fine-tuning of this response by lowering the sensitivity of the thyrotropes to CRH.

Role of melatonin in the control of growth and growth hormone secretion in poultry

The pineal hormone melatonin controls reproduction of photoperiodic mammals and is an integral part of the circadian organization in birds. Recent findings indicate an involvement of this hormone also in more basic physiological processes, including growth, development, and aging. Melatonin may modulate growth in poultry through interaction with transcriptional factors, through interaction with hormones involved in growth control, and by modulation of energy metabolism and decreasing physical activity. Our studies showed that a single melatonin injection increased plasma growth hormone (GH) concentrations in the Japanese quail. Specific serotonin receptor blocker ketanserin did not preclude a stimulatory action of melatonin on GH synthesis. Serotonin agonist quipazine increased GH levels but failed to enhance the stimulatory effect of melatonin. Pretreatment with melatonin in drinking water did not affect the magnitude of the GH response to subcutaneous (s.c.) administration of thyrotropin releasing hormone (TRH) that considerably stimulated GH secretion. Present data suggest that melatonin modulates rather central neural pathways involved in the control of GH synthesis at the hypothalamic level than the sensitivity of the pituitary gland.

Effects of protein kinase A inhibitor (H-89) on VIP- and GRF-induced release and mRNA expression of prolactin and growth hormone in the chicken pituitary gland

Vasoactive intestine polypeptide (VIP) and growth hormone releasing factor (GRF) stimulated an increase of cAMP accumulation with a concomitant release of PRL and GH, respectively. Release of PRL induced by VIP was partially suppressed by 5 and 25 microM of H-89, whereas VIP-induced gene expression of PRL was inhibited by all concentrations of H-89. Release and gene expression of GH induced by GRF was inhibited by H-89 in a dose-dependent manner and completely blocked by 25 microM of H-89. These results indicate that VIP-induced PRL release and gene expression may be mediated, at least in a part, by cAMP-dependent protein kinase pathway, whereas GRF-induced GH release and gene expression may be mediated predominantly by cAMP-dependent protein kinase.

In vivo effects of TRH, T3 and cGH on antibody production and T- and B-lymphocytes proliferation in immature male chickens

Newly hatched White Leghorn male chicks were used in this study. Different doses of T3 (0.1 or 1 ppm) or TRH (1 or 5 ppm) were administered in the feed for an 8-week period. Chicken growth hormone (cGH) (10 micrograms/kg BW) was injected (i.v.) into a different group of chicks twice daily for 1 week starting at 7 weeks of age. A different group received both T3 (0.1 and 1 ppm) and cGH. Serum concentrations of T4, T3 and GH, antibody production against sheep red blood cells (SRBC) and Brucella Abortus (BA), and in vitro proliferative response of both T- and B-lymphocytes to mitogenic stimulation were measured. Supplementation of T3 (1 ppm) significantly lowered T4 and increased T3 concentrations. No effect of any hormone treatment on antibody production was observed. T3 supplementation and cGH injection alone or with T3 (0.1 ppm) significantly increased blastogenic response of lymphocytes to either Con-A or LPS mitogenic stimulation. It was concluded that T3 and GH are involved in lymphocyte activity of chickens.

The effect of dietary iodine on the hatchability of eggs from two commercial strains of turkeys

Supplemental dietary iodine (3.5 mg/kg) was fed to two commercial strains [British United Turkeys (B) and Nicholas (N)] of turkey breeder hens. The basal diet contained .7 mg/kg of iodine. Observations were made on hen body weights, feed consumption, hatchability, egg weights, and egg functional characteristics to test the hypothesis that there are differences between commercial strains of turkey breeder hens in the dietary iodine requirement for reproductive success. Supplemental iodine decreased (P less than or equal to .05) functional egg characteristics of both strains. Egg production and hatchability were influenced by an interaction between strains and dietary iodine (P less than or equal to .05). In Strain B hens, egg production and hatchability declined (P less than or equal to .05) when hens were fed supplemental iodine but in Strain N hens no effects on hatchability were observed and egg production increased (P less than .05) with iodine supplementation. The decline in hatchability of eggs from Strain B hens was due to significant (P less than or equal to .05) increases in embryonic mortality during the 1st wk of incubation and during pipping. The treatments resulting in depressed hatchability caused embryos to rely more (P less than or equal to .05) on glycogenolysis than gluconeogenesis during pipping and hatching. The Strain B embryos utilized gluconeogenesis more during pipping (P less than or equal to .05) than Strain N embryos and embryos from Strain B iodine-fed hens had a lower rate of gluconeogenesis than those from hens not fed iodine. It is concluded that there are differences among strains of turkey breeder hens in their dietary iodine requirement for optimal hatchability.

Human pancreatic growth hormone-releasing factor (1-44) stimulates GH cells in an anuran amphibian (Rana perezi)

Subcellular responses of amphibian growth hormone (GH)-producing cells to in vivo administration of human pancreatic growth hormone-releasing factor (1-44) (hpGRF) were investigated. The volume density (Vv) of secretory granules (SG), rough endoplasmic reticulum (RER), and Golgi complex (GC) and the numerical density (Nv) of the granules were estimated by ultrastructural morphometry. Immunogold staining was applied to ultrathin sections using an antiserum to ovine GH to identify GH-producing cells. In vivo treatment with hpGRF significantly decreased the Vv of the SG and the Nv of medium SG after 6 hr. The peptide also stimulated development of the cellular biosynthetic machinery and increased the number of small SG 24 hr after stimulation. Four-day-stimulated GH cells did not recover control morphological appearances. These morphological results suggest that: (1) In vivo administered hpGRF stimulates GH cells in Rana perezi by inducing hormone release and enhances biosynthetic activity; (2) after four injections, the cellular response is more intense, indicating that GH cells remain hyperactive, probably because the exogenous hpGRF overcomes the endogenous inhibitory control of GH secretion.

Effect of thyrotropin-releasing hormone, triiodothyronine, and chicken growth hormone on plasma concentrations of thyroxine, triiodothyronine, growth hormone, and growth of lymphoid organs and leukocyte populations in immature male chickens

One-day-old White Leghorn male chicks were fed different levels of Thyrotropin Releasing Hormone (TRH) (1 and 5 ppm) or Triiodothyronine (T3) (.1 and 1 ppm) for an 8-wk period. In a second experiment, chicken growth hormone (cGH) (10 micrograms/kg of BW) was injected (iv) into different birds daily for 7 days starting at 7 wk of age. Different groups of birds received both T3 (.1 and 1 ppm) and cGH. Serum concentrations of thyroxine (T4), T3, and growth hormone (GH), lymphoid organ weights, total circulating white blood cells (WBC), and differential counts were measured following hormone treatments. It was found that T3, cGH, or a combination of both significantly lowered serum T4 concentrations. Triiodothyronine supplementation at 1 ppm, alone or with cGH significantly increased serum T3 concentrations. Chicken GH with T3 (.1 ppm) significantly increased serum GH concentrations. Thyrotropin releasing hormone supplementation did not affect serum concentrations of either T4, T3, or cGH. Relative bursa weights were greater in chicks that received T3 (1 ppm) or TRH (1 or 5 ppm) but not cGH. Relative spleen weights were enhanced in response to cGH alone or with T3 (1 ppm) but not TRH. Total WBC count was significantly increased in response to T3 (1 ppm). Supplementation of T3 (.1 or 1 ppm), TRH (1 ppm), and the combination of cGH and T3 (1 ppm) significantly increased the percentage of lymphocyte cell population. These results demonstrate the impact of feeding hormones on T3, T4, and cGH concentrations in the serum and suggest the involvement of the above hormones in the growth of lymphoid organs as well as the production of lymphocytes.

Triiodothyronine inhibition of thyrotropin-releasing hormone- and growth hormone-releasing factor-induced growth hormone secretion in anesthetized chickens

The ability of triiodothyronine (T3) to reduce basal and secretagogue-induced growth hormone (GH) release was examined in anesthetized young and adult male chickens. Infusion of T3 had no effect on basal plasma concentrations of GH in either young or adult chickens. However, GH secretion following challenge with either thyrotropin-releasing hormone (TRH) or growth hormone-releasing hormone (GRF) was reduced, in a dose-dependent manner, by the infusion of T3. In vivo sensitivity to T3 inhibition was greater with TRH- than GRF-stimulated GH release in either young (ED50 for TRH-induced GH release, 0.34 microgram T3/kg/min; ED50 for GRF-induced GH release, 0.49 microgram T3/kg/min) or adult chickens (ED50 for TRH-induced GH release, 0.11 microgram T3/kg/min; ED50 for GRF-induced GH release 1.89, micrograms T3/kg/min). Moreover, there was an increase in sensitivity of TRH-induced GH release to T3 with age.

Effect of thyroid hormones on growth hormone secretion in broiler chickens

Plasma concentrations of growth hormone (GH) were observed to be significantly elevated following the administration of thyrotropin-releasing hormone (TRH) in young (4- to 12-week-old) but not in adult (20-week-old) broiler chickens. However, adult sex-linked (dw) dwarf hens did respond to TRH. Treatment with triiodothyronine (T3) but not thyroxine (T4) (at 1 ppm in the diet from hatch) consistently and significantly reduced the growth rate and decreased the plasma concentrations of GH following TRH injection in normal (DwDw males or Dw-females), hemizygous dwarf (dw-) female, and heterozygous (Dwdw) male lines of broiler chickens. Similarly, T3 was significantly more effective than T4 in inhibiting the increase in plasma concentrations of GH following TRH injection in broiler chicks made hypothyroid by methimazole administration.

The influence of thyrotropin releasing hormone on in vivo prolactin release and in vitro prolactin, luteinizing hormone, and growth hormone release from dispersed pituitary cells of the young turkey (Meleagris gallopavo)

Intravenous administration of 0.025, 0.25, or 2.5 micrograms/kg thyrotropin releasing hormone (TRH) to 4-week-old female turkeys induced a dose-dependent increase (P = 0.004) in serum prolactin (PRL) 15 min post-treatment. Dispersed anterior pituitary cell cultures were utilized to determine the effect of TRH on cellular release of PRL, luteinizing hormone (LH), and growth hormone (GH). In the first experiment, cells from 13-week-old male turkeys were initially incubated for 24 hr in Medium 199 (M-199) plus 10% turkey serum and then placed in M-199 plus 10(-10) to 10(-4) M TRH for 5 hr. Incubation with TRH produced no change in PRL release from that of spontaneous release (P = 0.854). However, 10(-5) and 10(-4) M TRH induced LH release (P less than 0.0001). The TRH-induced GH response was parabolic (P less than 0.0001), with the maximal release at 10(-8) M. The second experiment, utilizing pituitary cells from 7-week-old females, studied these responses on 3, 5, and 7 days of monolayer incubation. TRH failed to induce a PRL release in all tests (P greater than 0.162), although hypothalamic extract induced a large release (P less than 0.0001) of PRL each time. Both 10(-6) and 10(-4) M TRH induced a LH release on Day 3 while only 10(-4) M did so on Day 5, and none of the doses elicited a release on Day 7. The parabolic GH response generally persisted in all tests.(ABSTRACT TRUNCATED AT 250 WORDS)

Hypothalamo-adenohypophyseal-thyroid interrelationships in the developing chick embryo. VII. Immunocytochemical demonstration of thyrotrophin-releasing hormone

Thyrotrophin-releasing hormone (TRH) was demonstrated immunocytochemically in the infundibulum of the chick embryo as early as Day 4.5 of incubation. From Days 4.5 through 19.5 of embryonic development there is a gradual increase within the developing hypothalamus in the number of TRH-positive perikarya as well as the amount of immunoreactive-TRH (IR-TRH) per cell. There are no abrupt changes in either parameter during the critical time period (Days 10.5-13.5 of incubation) in the maturation of the pituitary-thyroid axis. Thus, although TRH is probably not directly responsible for the dramatic increase in the number of thyrotrophin-producing cells which occurs in the pars distalis of 10.5- to 11.5-day-old embryos (R. C. Thommes, J. B. Martens, W. E. Hopkins, J. Caliendo, M. J. Sorrentino, and J. E. Woods (1983). Gen. Comp. Endocrinol. 51, 434-443) the marked change in the activity of the pituitary-thyroid unit at this time may well reflect the response of these newly differentiated thyrothrophs to low levels of plasma TRH. This hypothesis is supported by the observations that between Days 10.5 and 11.5 the hypothalamic-adenohypophyseal-thyroid (HAT) axis is first responsive to cold (R. C. Thommes, J. B. Martens, J. B. Hopkins, D. A. Griesbach, D. J. Williams, M. J. Sorrentino, P. Wernke, and J. E. Woods. In "Proceedings, Ninth International Symposium on Comparative Endocrinology Hong Kong, 7-11 December 1981" (B. Lofts, ed.). Hong Kong Univ. Press, Hong Kong, in press) and also that the pituitary-thyroid unit exhibits a marked increase in its sensitivity to exogenous TRH (R. C. Thommes, D. J. Williams, and J. E. Woods (1984). Gen. Comp. Endocrinol. 55, 275-279).

Purification and properties of chicken growth hormone and the development of a homologous radioimmunoassay

Highly purified growth hormone (GH) has been isolated from pituitary glands of chicken (Gallus domesticus), and a specific homologous radioimmunoassay (RIA) has also been developed. The purified chicken GH was active in the rat tibia bioassay and it gave a dose-dependent response which paralleled that of the bovine GH standard. High pressure liquid chromatography revealed that the purified chicken GH was homogenous. Chicken GH had an Rf value of 0.2 in disc electrophoresis, and a MW of 26,000 from sodium dodecyl sulfate-gel electrophoresis. The isoelectric point was estimated to be 7.6 by gel isoelectric focusing. The amino acid composition of chicken GH was found to be similar to that of mammalian GH, and the NH2-terminal amino acid was threonine. Partial sequencing (114 amino acids) of the chicken GH showed 79% homology with bovine GH. An antiserum was developed to the purified chicken GH in a rabbit, and it was used to develop a homologous RIA using 125I-labeled chicken GH as the ligand. The purified chicken GH was iodinated via the lactoperoxidase method to a specific activity of approximately 100 microCi/micrograms. Plasma from chickens, medium from incubation of pituitary glands, and homogenates of pituitary glands gave parallel dilution-response curves with the chicken GH standard. Mammalian GH, prolactin (PRL), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) showed no cross-reaction with the 125I-labeled chicken GH. Purified turkey GH showed parallel dose response with the chicken GH, but purified turkey PRL did not cross-react. Chicken FSH and LH also showed no inhibition of binding. The minimum detectable concentration of the assay was 0.93 ng/tube, and the intraassay and interassay coefficients of variation were 9 and 16%, respectively. The specific binding of 125I-labeled chicken GH to a microsomal fraction isolated from chicken liver was identified, and the specific binding was generally low (1-4%). Turkey PRL, and chicken LH and FSH showed no inhibition of the 125I-labeled chicken GH hepatic binding and the ontogeny of the hepatic GH receptor binding sites in male and female chickens was examined.

Growth hormone: its physiology and control

Growth hormone (GH) is a protein hormone produced by the somatotrophs of the anterior pituitary gland of birds and other vertebrates. The secretion of GH in birds is under hypothalamic control; it involves three peptidergic releasing factors: growth hormone-releasing factor (GRF) (stimulatory); thyrotropin-releasing hormone (TRH) (stimulatory); and somatostatin (SRIF) (inhibitory). In addition, there is evidence for effects of biogenic amines (including serotonin and norepinephrine) and prostaglandins at the level of the hypothalamus and possibly also the pituitary gland. In all avian species examined, plasma concentrations of GH are high in young posthatching chicks but low in the adult and embryo. The difference in plasma concentrations of GH between young and adult birds is due to both greater GH secretion and reduced clearance. The lower secretion of GH in adult birds reflects fewer somatotrophs in the pituitary, changes in somatotroph structure, and reduced GH responses to TRH or GRF administration. There is only limited data on the role of GH in birds. GH appears to be required for normal growth; acting at least in part by increasing somatomedin production. However, plasma concentrations of GH do not necessarily correlate with growth rate. For instance, in chicks with reduced growth rate owing to either goitrogen or protein deficiency in the diet, plasma concentrations of GH are elevated. GH also can influence lipid metabolism by increasing lipolysis, decreasing lipogenesis, and stimulating the uptake of glucose by adipose tissue. The physiological significance of these actions is, however, not established. In addition, GH affects the secretion of other hormones, the immune system, and perhaps also the reproductive system.

Stimulation of growth hormone secretion by human pancreatic growth-hormone-releasing factor and thyrotrophin-releasing hormone in anaesthetized chickens

Sodium pentobarbitone anaesthesia depressed the concentration of growth hormone (GH) in the plasma of young (6 weeks of age) and old (22-30 weeks of age) domestic fowl. In both cases the concentration was reduced (P less than 0.05) within 10 min and had declined (P less than 0.001) to stable low levels (less than 5 ng/ml) within 50 min. The intravenous administration of synthetic human pancreatic growth-hormone-releasing factor (hpGRF) (10 micrograms/kg) (2 X 10(-9) mol/kg) increased (P less than 0.01) the GH concentration in both the young and old birds. This effect was observed irrespective of whether the birds were conscious or anaesthetized. The magnitude of the response in conscious young birds (164 ng/ml) was, however, greater (P less than 0.01) than that in anaesthetized chicks (64 ng/ml). The response in anaesthetized adult fowl (18.8 ng/ml) was also less (P less than 0.05) than that in their conscious counterparts (42.8 ng/ml). The GH response in conscious and anaesthetized 6-week-old birds to hpGRF was greater (P less than 0.01) than that in the corresponding adult birds. Thyrotrophin-releasing hormone (TRH) (10 micrograms/kg (2.8 X 10(-8) mol/kg); iv) also provoked (P less than 0.01) GH secretion in conscious and anaesthetized young birds and in anaesthetized (but not conscious) adults. Anaesthesia blunted (P less than 0.01) the GH response to TRH in the immature cockerels, although the response was greater (P less than 0.05) than that in anesthetized adults.(ABSTRACT TRUNCATED AT 250 WORDS)

Stimulation of growth hormone secretion in dwarf chickens by thyrotrophin-releasing hormone (TRH) or human pancreatic growth-hormone-releasing factor (hpGRF)

The basal plasma growth hormone (GH) level in adult sex-linked dwarf hens was elevated in comparison with autosomal dwarf hens and with control (Cornell K strain) laying hens. The iv administration of thyrotrophin-releasing hormone (TRH) (10 micrograms/kg) had no effect on GH secretion in control hens but slightly (1.2-fold) and transiently (for 10 min) increased the GH level in the autosomal dwarfs and greatly (8.7-fold) increased the GH level in the sex-linked dwarfs, in which it remained elevated for at least 30 min after injection. The iv administration of human pancreatic GH-releasing factor (hpGRF) (10 micrograms/kg) stimulated GH release in each strain. The response in the sex-linked dwarfs was greater than that in the autosomal dwarfs and the control hens but less than that elicited by TRH. These results suggest that the increased basal GH level in the sex-linked dwarfs results from an increased responsiveness to provocative stimulation.

Synthetic human pancreatic growth hormone releasing factor (GRF) stimulates growth hormone secretion in the domestic fowl (Gallus domesticus)

Synthetic human pancreatic Growth Hormone-Releasing Factor (hpGRF) elevated the plasma concentration of growth hormone (GH) in young and adult domestic fowl. This in vivo effect of hpGRF appeared to be largely similar for both the 32 amino-acid (hpGRF 1-32) or 40 amino-acid (hpGRF 1-40) polypeptide, although the effect of hpGRF 1-32 was more prolonged than that of hpGRF 1-40 in adult domestic fowl. The increase in plasma GH concentrations following hpGRF administration (10 micrograms/kg) was somewhat greater in young than adult chickens (the increase in plasma concentration of GH being 230 ng/ml at 1 week old, 282 ng/ml at 6 week old, 241 ng/ml at 10 weeks and 150 ng/ml in adults). In the adult domestic fowl hpGRF stimulated a greater increase in the plasma concentration of GH than did thyrotropin-releasing hormone (TRH). However in the young chicks TRH was more active. The in vitro release of GH from dispersed chicken pituitary cells was elevated by hpGRF (1-32) and hpGRF (1-40).